Loading...
Can Alzheimer disease be prevented by amyloid-β immunotherapy?
Alzheimer disease (AD) is the most common form of dementia. The amyloid-β (Aβ) peptide has become a major therapeutic target in AD on the basis of pathological, biochemical and genetic evidence that supports a role for this molecule in the disease process. Active and passive Aβ immunotherapies have...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Artigo |
| Language: | Inglês |
| Published: |
2010
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2864089/ https://ncbi.nlm.nih.gov/pubmed/20140000 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/nrneurol.2009.219 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|